{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:22:01Z","timestamp":1778170921263,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.humpath.2017.10.019","type":"journal-article","created":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T23:02:19Z","timestamp":1509231739000},"page":"114-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report"],"prefix":"10.1016","volume":"74","author":[{"given":"Koping","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Hau","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Chi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Wu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2017.10.019_bb0005","series-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","first-page":"68","article-title":"Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1","author":"Bain","year":"2008"},{"key":"10.1016\/j.humpath.2017.10.019_bb0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00000478-199203000-00003","article-title":"T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy","volume":"16","author":"Abruzzo","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.10.019_bb0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.humpath.2009.11.003","article-title":"8p11 myeloproliferative syndrome: a review","volume":"41","author":"Jackson","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2017.10.019_bb0020","series-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","first-page":"54","article-title":"Mastocytosis","author":"Horny","year":"2008"},{"key":"10.1016\/j.humpath.2017.10.019_bb0025","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/jcp.2008.058073","article-title":"Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3","volume":"61","author":"Tzankov","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2017.10.019_bb0030","doi-asserted-by":"crossref","first-page":"526129","DOI":"10.1155\/2014\/526129","article-title":"An adult patient with systemic mastocytosis and B-acute lymphoblastic leukemia","volume":"2014","author":"Iliakis","year":"2014","journal-title":"Case Rep Med"},{"key":"10.1016\/j.humpath.2017.10.019_bb0035","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/ajh.24426","article-title":"Next-generation sequencing in systemic mastocytosis: derivation of a mutation-augmented clinical prognostic model for survival","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2017.10.019_bb0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.leukres.2011.10.009","article-title":"Unique association of systemic mastocytosis and myeloid\/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene","volume":"36","author":"Mayeur-Rousse","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2017.10.019_bb0045","first-page":"801","article-title":"Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case","volume":"7","author":"Duckworth","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2017.10.019_bb0050","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/leu.2008.287","article-title":"Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias","volume":"22","author":"Gotlib","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2017.10.019_bb0055","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1309\/AJCPUD6W1JLQQMNA","article-title":"Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature","volume":"143","author":"Kumar","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2017.10.019_bb0060","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ajh.24553","article-title":"Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771730388X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771730388X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T04:01:49Z","timestamp":1547265709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681771730388X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":12,"alternative-id":["S004681771730388X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2017.10.019","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}